AlphaProteo was created to advance drug design and disease understanding by helping researchers configure high-strength proteins that bind to molecules.
The alliance aims to mitigate the human and economic price related to the improper prescribing and dispensing of controlled substances.
The acquisition adds governance, risk and compliance capabilities for behavioral health firms to Kipu's platform.
Lingo tracks glucose in real time and delivers personal insights and coaching.
The collaboration will leverage Genetic Leap's RNA-targeted AI platform to create genetic medicines against selected targets.
The company will use the funds to expand its SubtleSYNTH technology to include brain imaging.
The technology marries advanced proficiency of full prescription hearing aids with the contemporary design of consumer earbuds.
The company will use the funds to expand its geographic reach and presence in life sciences.
The alliance aims to help athletes train and monitor their vital signs with mobile fitness devices, including Amazfit smartwatches and Helio ring.
The project aims to promote AI-powered tech support for care providers and help streamline administrative tasks while boosting clinical decision-making.
